Medication info
Ciprofloxacin Hydrochloride Hydrate 250 mg Tablets

Ciprofloxacin Hydrochloride Hydrate 250 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
TDS Pharm Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets, 100 tablets
Approval status
Active

MFDS item code 201500661 · Approved 2015.02.09 · Insurance code 679801410

Summary

Main use
Treatment of bacterial infections (urinary tract, respiratory tract, skin, etc.)
Who takes it
Adults
Adult dose
○ Adults: Administer 250 ~ 500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms resolve. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following equations: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the single dose may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored closely after administration. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
TDS Pharm Co., Ltd.

Efficacy & effects

Treatment of bacterial infections (urinary tract, respiratory tract, skin, etc.)

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute simple cystitis
  • acute pyelonephritis
View approved original text

This medication is used to treat infections caused by various bacteria including Escherichia coli, Salmonella, and Staphylococcus. It is effective against respiratory infections excluding acute bronchitis and community-acquired pneumonia, as well as ear, nose, and throat infections, bacterial prostatitis, and various urinary tract infections. It is also used for gastrointestinal infections, biliary tract infections, skin and soft tissue infections, bone and joint infections, gynecological infections, and peritonitis. As a fluoroquinolone antibiotic, it should be prescribed cautiously only when no alternative treatment is available for certain specific conditions. This medication is used to effectively treat a variety of bacterial infections.

How to take

Adult dose

○ Adults: Administer 250 ~ 500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg twice daily. For acute infections, treatment is usually given for 5 ~ 10 days, and continued for at least 3 days after symptoms resolve. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients on hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following equations: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the single dose may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored closely after administration. Adjust the dose as appropriate according to symptoms.

Precautions

This medication can cause serious side effects such as tendonitis and tendon rupture; if these symptoms occur, usage must be stopped immediately. It is contraindicated in patients with severe myasthenia gravis due to risk of exacerbation. This medication is used restrictively for specific bacterial infections when no other therapy is available. Elderly patients, those with impaired renal function, and patients taking corticosteroids are at increased risk of tendon rupture. This medication can affect the central nervous system, potentially causing seizures or psychiatric symptoms; it should be used cautiously in patients with epilepsy or central nervous system disorders. Pregnant or potentially pregnant women, nursing mothers, and growing adolescents under 18 years should not use this medication. There may also be severe side effects when combined with certain medications; consult a healthcare provider if other medications are being taken. During treatment, avoid strong sunlight and UV exposure; if skin rash or photosensitivity occurs, discontinue use immediately. It may influence blood glucose levels, so diabetic patients should check their blood sugar frequently and treat any symptoms of hypoglycemia immediately. Patients with heart conditions or risk factors should consult a physician thoroughly before using this medication. This medication may affect kidney function, so patients with renal disease should undergo regular renal function tests. Overdose can cause nephrotoxicity, necessitating immediate emergency treatment, and adequate hydration is essential. This medication should be stored out of the reach of children, avoiding direct sunlight or UV exposure. It is important to consult healthcare personnel immediately if any abnormal symptoms or side effects are suspected during use.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, hematocrit decrease, granulocyte decrease, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate secretion of antidiuretic hormone (SIADH), allergic reaction, allergic edema, angioedema, anaphylactic reaction, anaphylactoid shock, serum sickness-like reaction, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, suicidal thoughts, suicide attempts, self-harming behaviors similar to suicide, hallucinations, psychotic reactions, substance-induced psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory loss, loss of taste, tremors, convulsions, vertigo, delirium, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, dysmetria, peripheral neuropathy, multiple neuropathies, visual disturbances, chromatopsia, diplopia, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular arrhythmia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, loss of appetite, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, indigestion, membranous colitis, colitis with blood in stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, mucocutaneous syndrome, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and cramps, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, kidney dysfunction, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpuric rash, injection site rash, injection site itching, injection site urticaria, aneurysm, aortic dissection, heart valve regurgitation, heart valve insufficiency, muscle weakness, rhabdomyolysis, interstitial pneumonia, visual impairment, acute respiratory distress, palpitations, abdominal or lower limb edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container at a temperature between 1 and 30 degrees Celsius. Proper storage maintains the effectiveness of the medication and prevents deterioration.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets, 100 tablets

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.